[HTML][HTML] COVID-19 and liver disease: mechanistic and clinical perspectives
Our understanding of the hepatic consequences of severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) infection and its resultant coronavirus disease 2019 (COVID …
coronavirus 2 (SARS-CoV-2) infection and its resultant coronavirus disease 2019 (COVID …
[PDF][PDF] Alcohol‐Associated Liver Disease Before and After COVID‐19—An Overview and Call for Ongoing Investigation
The Coronavirus Disease 2019 (COVID‐19) pandemic has exacted a heavy toll on patients
with alcohol‐associated liver disease (ALD) and alcohol use disorder (AUD). The collective …
with alcohol‐associated liver disease (ALD) and alcohol use disorder (AUD). The collective …
SARS-CoV2-specific humoral and T-cell immune response after second vaccination in liver cirrhosis and transplant patients
DF Ruether, GM Schaub, PM Duengelhoef… - Clinical …, 2022 - Elsevier
Background & Aims Detailed information on the immune response after second vaccination
of cirrhotic patients and liver transplant (LT) recipients against severe acute respiratory …
of cirrhotic patients and liver transplant (LT) recipients against severe acute respiratory …
[HTML][HTML] Risk factors of severe COVID-19: a review of host, viral and environmental factors
The clinical course and outcome of COVID-19 are highly variable, ranging from
asymptomatic infections to severe disease and death. Understanding the risk factors of …
asymptomatic infections to severe disease and death. Understanding the risk factors of …
[HTML][HTML] Peer Reviewed: COVID-19 Severity and Mortality Among Chronic Liver Disease Patients: A Systematic Review and Meta-Analysis
R Nagarajan, Y Krishnamoorthy, S Rajaa… - Preventing Chronic …, 2022 - ncbi.nlm.nih.gov
Methods We searched for studies reporting COVID-19 outcomes among CLD and non-CLD
patients in databases including Medline, EMBASE, ScienceDirect, Google Scholar, and …
patients in databases including Medline, EMBASE, ScienceDirect, Google Scholar, and …
Outcomes of SARS-CoV-2 infection in patients with chronic liver disease and cirrhosis: a national COVID cohort collaborative study
Background & Aims In patients with chronic liver disease (CLD) with or without cirrhosis,
existing studies on the outcomes with severe acute respiratory syndrome coronavirus 2 …
existing studies on the outcomes with severe acute respiratory syndrome coronavirus 2 …
[HTML][HTML] SARS-CoV-2 infection in patients with autoimmune hepatitis
Background & Aims Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and
coronavirus disease 2019 (COVID-19) continues to have a devastating impact across the …
coronavirus disease 2019 (COVID-19) continues to have a devastating impact across the …
Impact of COVID-19 on the liver and on the care of patients with chronic liver disease, hepatobiliary cancer, and liver transplantation: An updated EASL position paper
T Marjot, CS Eberhardt, T Boettler, LS Belli… - Journal of …, 2022 - Elsevier
The COVID-19 pandemic has presented a serious challenge to the hepatology community,
particularly healthcare professionals and patients. While the rapid development of safe and …
particularly healthcare professionals and patients. While the rapid development of safe and …
[HTML][HTML] Deaths induced by compassionate use of hydroxychloroquine during the first COVID-19 wave: an estimate
A Pradelle, S Mainbourg, S Provencher… - Biomedicine & …, 2024 - Elsevier
Background During the first wave of COVID-19, hydroxychloroquine (HCQ) was used off-
label despite the absence of evidence documenting its clinical benefits. Since then, a meta …
label despite the absence of evidence documenting its clinical benefits. Since then, a meta …